Cargando…
Incidence and Risk of Proteinuria with Aflibercept in Cancer Patients: A Meta-Analysis
BACKGROUND: Aflibercept is a human recombinant fusion protein with antiangiogenic effects that functions as a decoy receptor to bind vascular endothelial growth factor A. Proteinuria is one of its major adverse effects with a substantial variation in the incidence rate, and the overall risk of prote...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218823/ https://www.ncbi.nlm.nih.gov/pubmed/25365378 http://dx.doi.org/10.1371/journal.pone.0111839 |